News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Conference News ESC 2019 Updated EAS/ESC Dyslipidemia Guidelines Lower LDL Targets, Broaden Risk Categories Yael L. Maxwell September 06, 2019
News Daily News New AHA Guidance on Omega-3 Fatty Acids for High Triglycerides Michael O'Riordan August 21, 2019
News Daily News A Boost for Prescription Omega-3s? Not Yet: FDA Panel Set for November Yael L. Maxwell August 14, 2019
News Daily News Most Supplements and Diets Don’t Lower CVD or Mortality Risks Michael O'Riordan July 09, 2019
News Daily News Will Less Aggressive Lp(a) Targets Do the Trick? Time and Clinical Trials Will Tell Yael L. Maxwell April 24, 2019
News Conference News ACC 2019 REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events Yael L. Maxwell March 22, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2018 Shelley Wood November 30, 2018
News Conference News AHA 2018 AHA 2018: New Cholesterol Guidelines, Fish Oil, Diabetes Meds, and Inflammation Blow Into the Windy City Shelley Wood November 05, 2018